Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ERAS
ERAS News & Events
-
Add to Watchlist
Trade ERAS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ERAS News
ImmunityBio's Anktiva Receives EU Approval, Boosting Stock
13h ago
stocktwits
Erasca CMO Sells Shares Under 10b5-1 Plan
5d ago
NASDAQ.COM
Erasca CMO Sells Shares in SEC Filing
5d ago
Fool
Erasca Reports Q4 2025 Financial Results with Reduced Losses
Mar 12 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 06 2026
Benzinga
Tango Therapeutics Shares Surge 24% to New 52-Week High Following Collaboration with Erasca
Mar 05 2026
seekingalpha
Erasca Partners with Tango for Clinical Trial of ERAS-0015
Mar 05 2026
Newsfilter
FDA's Accelerated Approval Framework Drives Cancer Treatment Advances
Feb 17 2026
Newsfilter
Show More News
ERAS Events
No data
ERAS Monitor News
Erasca Inc. Closes $258.8 Million Upsized Public Offering
Jan 26 2026
Erasca's General Counsel Sells Shares Amid Market Confidence
Jan 15 2026
Erasca Inc Surpasses Analyst Target Price, Stock Rises
Jan 09 2026
Erasca Inc Surges After Analyst Upgrade
Jan 07 2026
ERAS Earnings Analysis
No Data
People Also Watch